Research Article
Serum ICAM-1 as a Predictor of Prognosis in Patients with Acute Ischemic Stroke
Table 2
Risks variables for poor outcome at 3 months in AIS patients.
| | OR | 95% CI | value |
| Age, years | 1.35 | 0.843-1.418 | 0.231 | Male, (%) | 1.16 | 0.902-1.194 | 0.365 | NHISS on admission | 0.65 | 0.436-0.803 | 0.058 | Hypertension, (%) | 1.33 | 0.887-1.379 | 0.272 | Diabetes mellitus, (%) | 1.31 | 0.835-1.352 | 0.107 | Coronary heart disease, (%) | 1.18 | 0.891-1.205 | 0.329 | Atrial fibrillation, (%) | 1.24 | 0.858-1.287 | 0.353 | Systolic blood pressure, mmHg | 1.35 | 0.774-1.386 | 0.432 | Diastolic blood pressure, mmHg | 1.31 | 0.970-1.361 | 0.504 | Fasting blood-glucose, mmol/l | 1.27 | 0.859-1.304 | 0.766 | Total cholesterol, mmol/l | 1.20 | 0.831-1.275 | 0.520 | ICAM-1, pg/ml | 0.52 | 0.318-0.839 | 0.007 |
|
|
AIS: acute ischemic stroke; NIHSS: National Institute of Health Stroke Scale; ICAM-1: intercellular adhesion molecule-1.
|